Skip to content
Screener

Oscar Health OSCR Cash, Cash Equivalents, and Marketable Securities

Cash, Cash Equivalents, and Marketable Securities at other companies

CVS Health logo
CVS HealthCVS
$14.82B
UnitedHealth Group logo
UnitedHealth GroupUNH
$50.29B+7.9%
CBIZ logo
CBIZCBZ
$45.05M+9.7%
Community Financial System logo
Community Financial SystemCBU
$2.85B+2.2%

Other financials

Income statement

See full
Revenue$4.9B+70.4%
Operating income$388.6M+269%
Net income$361.8M+258%
EPS (diluted)$1.10+224%

Balance sheet

See full
Cash & equivalents$4.1B+56.3%
Total debt$431.6M+43.9%
Total equity$2.1B+77.1%
Total assets$11.2B+75.9%

Cash flow

See full
Operating cash flow$2.1B+311%
CapEx$11.8M+26.8%
Free cash flow$2.1B+316%

Valuation

See full
Market cap$8.61B+113%
Enterprise value$4.94B+189%
P/E15.6×
P/S0.6×+0.2×

Profitability

See full
Operating margin4.1%
Net margin3.6%
FCF margin-8.2%

Returns & leverage

See full
Return on equity34.3%
Debt / equity0.2×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The source filing: Oscar Health’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001568651-26-000069
(in thousands)June 30, 2026 / Amortized CostJune 30, 2026 / Fair ValueDecember 31, 2025 / Amortized CostDecember 31, 2025 / Fair Value
Due in one year or less$4,481,630$4,479,906$1,213,011$1,216,461
Due after one year through five years1,534,5821,528,2551,372,0381,385,735
Due after five years through ten years70,09369,60681,97382,843
Total$6,086,305$6,077,767$2,667,022$2,685,039

Item 1. Financial Statements

FAQ

What is Oscar Health's cash, cash equivalents, and marketable securities?
Oscar Health (OSCR) reported cash, cash equivalents, and marketable securities of $6.08B in Q2 2026.
How has Oscar Health's cash, cash equivalents, and marketable securities changed year-over-year?
Oscar Health's cash, cash equivalents, and marketable securities increased by 118.5% year-over-year, from $2.78B to $6.08B.
What is the long-term trend for Oscar Health's cash, cash equivalents, and marketable securities?
Over 3 years (2022 to 2025), Oscar Health's cash, cash equivalents, and marketable securities has grown at a 18.3% compound annual growth rate (CAGR), from $1.62B to $2.69B.
What does cash, cash equivalents, and marketable securities mean?
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.

Ask your AI about Oscar Health's cash, cash equivalents, and marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude